BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  BioXcel Therapeutics Provides Clinical and Business Update

  February 5, 2025

   · 

  12 min read
• Press Releases

  Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

  February 5, 2025

   · 

  1 min read
• Press Releases

  Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025

  February 5, 2025

   · 

  3 min read
• Press Releases

  JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2025 Showcase Research from Its Investigational Treatments for Lysosomal Storage Disorders

  February 5, 2025

   · 

  13 min read
• Press Releases

  Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024

  February 5, 2025

   · 

  24 min read
• Press Releases

  Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease

  February 5, 2025

   · 

  4 min read
• Press Releases

  Aprea Therapeutics Announces Strategic IP Portfolio Evolution in DNA Damage Response (DDR) Cancer Therapeutics

  February 5, 2025

   · 

  5 min read
• Press Releases

  Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

  February 5, 2025

   · 

  10 min read
• Press Releases

  E-Star BioTech Announces Dosing of First Patient in Phase 2 Clinical Trials of MANP in Resistant Hypertension

  February 5, 2025

   · 

  2 min read
• Press Releases

  e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025

  February 5, 2025

   · 

  2 min read